Search

Hereditary Blood Cancers | Hereditary Cancer Syndromes | UT Southwestern Medical Center

VHL | Hereditary Cancer Syndromes | UT Southwestern Medical Center

https://utswmed.org/conditions-treatments/genetics-and-hereditary-cancers/hereditary-cancer-syndromes/vhl/

Von Hippel-Lindau (VHL) Syndrome is often caused by a pathogenic or likely pathogenic variant in the VHL gene. UT Southwestern is recognized as a VHL Alliance Clinical Care Center, a designation that emphasizes our commitment to providing outstanding coordinated care for individuals with hereditary kidney cancer syndromes.

Experienced geneticists at UT Southwestern use the latest genetic testing methods, such as panel testing, to look for changes in genes related to cancer risk.

The UT Southwestern breast cancer team offers the latest in diagnostic technologies, such as ultrasound or breast MRI.

Discover comprehensive breast cancer treatment options at UT Southwestern. Our specialized team provides personalized care for every stage. Explore innovative approaches now.

Find out more about the breast cancer clinical trials currently available at UT Southwestern.

The purpose of this study is to test the effectiveness, safety, and tolerability of nivolumab in combination with chemotherapy drug nab-paclitaxel and/or another immunotherapy drugs including, but not limited to, ipilimumab in participants with breast cancer.

Learn who is at risk of colorectal cancer and what the symptoms are.

Types of colorectal cancer treated at UT Southwestern include rectal cancer and early-onset colorectal cancer.

UT Southwestern uses the latest diagnostic technologies to screen for colorectal cancer and help ensure an accurate diagnosis.